Mexico: Proven commercial use required for trademarks to achieve acquired distinctiveness

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Mexico: Proven commercial use required for trademarks to achieve acquired distinctiveness

Sponsored by

olivares-400px.jpg

On August 10, 2018 several modifications to the Mexican Industrial Property Law entered into force, resulting in some new IP figures being recognised in Mexico.

One of the new legal concepts included in the Law is 'acquired distinctiveness,' more commonly known as 'secondary meaning', which allows the registration of trademarks that can be considered as not initially distinctive, but owing to their commercial use have acquired distinctiveness.

However, these modifications still need to be complemented with regulation and are yet to be published in the Official Gazette.

In light of this there are no clear guidelines to determine the evidence required to support an application for a trademark filed based on acquired distinctiveness, and so it is not clear how The Mexican Institute of Industrial Property (IMPI) will examine these applications when filed.

In order to be able to demonstrate that a trademark has acquired distinctiveness it is necessary to prove that it has been used in the market and that consumers recognise the trademark in relation to the goods and/or services that it distinguishes. This is to ensure that the trademark complies with its main requisite, i.e. that it is sufficiently distinctive to enable its goods/services to be distinguished from others in the market.

Factors that can support the distinctiveness of the trademark in the market include:

  • surveys;

  • the date of first use of the mark in Mexico;

  • the period of time of continued use and advertisement of the trademark in Mexico;

  • the volume of sales of the goods/services identified with the trademark during the last three years.

In any case, until the regulations to the industrial property law are published in the Official Gazette, it will be necessary to meet with examiners to determine whether or not this evidence is sufficient to obtain a favourable resolution from the authorities.

caraza-wilma.jpg

Wilma Caraza


Olivares

Pedro Luis Ogazón No 17

Col San Angel

01000 México DF

Tel: +5255 53 22 30 00

Fax: +5255 53 22 30 01

olivlaw@olivares.com.mx

www.olivares.com.mx


more from across site and SHARED ros bottom lb

More from across our site

Yossi Sivan explains how Israeli judgment is a pro-brand owner departure from the norm and why it sends a strong message that corporate structures are not always a shield
Halim Shehadeh, group CEO of IP firm CWB, says that in the rush to discuss what AI can do, IP firms are overlooking the more important question of whether they are ready
Caitlin Heard, who formally joined the firm from CMS last month, says she is excited by the ‘energy’ of the London office
Ranjna Mehta-Dutt, who moved to Chadha & Chadha after 25 years at Remfry & Sagar, says the firm plans to expand its life sciences practice through targeted recruitment and dedicated teams for bigger clients
The initial contempt of court claim targeted Stobbs and the firm’s client for allegedly interfering with the administration of justice
Acquisition of platform developed by Boehmert & Boehmert lawyer set to create a combined platform for patent drafting and prosecution in Europe
Partner Rob Jacob unveils plans to offer a beginning-to-end trademark service, how to make prosecution profitable, and why IP ‘buy-in’ from the CEO stands the firm in good stead
Attorneys at Di Blasi, Parente & Associados share how the protection of trade secrets strengthens innovation by bringing together legal practice, regulatory developments, and established international references
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
Gift this article